ProAxsis is a commercial protease biomarker-led research company, supporting drug development and clinical research through specialist biomarker insights. ProAxsis focuses on the measurement of active protease biomarkers of disease, and supports pharmaceutical, biotech and research organisations through: - provision of immunoassay and point-of-use products - specialist clinical research services - bespoke assay development and scientific collaboration The company combines deep scientific expertise with proprietary technology to support drug development, translational research and clinical trial programmes, particularly in respiratory disease. With capabilities spanning research-use assay products, specialist sample testing and bespoke scientific collaboration, ProAxsis delivers high-quality biomarker insight designed to support more effective research and development programmes.
Looking for a particular ProAxsis employee's phone or email?
The ProAxsis annual revenue was $560000 in 2026.
Louise Murphy is the Managing Director of ProAxsis.
4 people are employed at ProAxsis.
ProAxsis is based in Antrim, Northern Ireland.
The NAICS codes for ProAxsis are [54, 541, 5417, 54171, 541714].
The SIC codes for ProAxsis are [873, 87].